Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression

Nonalcoholic fatty liver disease (NAFLD), ranging from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH), is the leading cause of chronic liver diseases. Until now, no medications for NAFLD have been approved by relevant governmental agencies. Dual‐specificity phosphatase 9 (Dusp9) is...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hepatology
Main Authors: Ye, Ping, Xiang, Mei, Liao, Hua, Liu, Jijun, Luo, Hongbo, Wang, Yayun, Huang, Ling, Chen, Manhua, Xia, Jiahong
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590435/
https://ncbi.nlm.nih.gov/pubmed/30063256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30198
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki